When tested separately on 44,755 already completed ultrasound exams, the artificial intelligence (AI) tool improved radiologists' ability to correctly identify the disease by 37 percent and reduced the number of tissue samples, or biopsies, needed to confirm suspect tumors by 27 percent.
The research was sparked by the pandemic and set out to build an AI tool to predict how much extra oxygen a COVID-19 patient may need in the first days of hospital care, using data from across four continents.
Telehealth and telemedicine emerged as essential communications tools during the COVID-19 pandemic as alternatives to face-to-face consultation between patients and physicians.